Date:3/1/2013

g facial photodamage in a pair of identical twins, P&G assessed the results of a long-term treatment regimen with a commercially available cosmetic product (Olay Professional Pro-X Intensive Wrinkle Protocol). The twin showing more facial skin photodamage at baseline (Twin "B") was placed on a daily regimen of cosmetic products designed to treat the signs of photoaging. The twin showing less facial photodamage (Twin "A") did not change from her current skin care treatment program, serving as the control. The cosmetic regimen included a deep wrinkle treatment, a daily moisturizer with SPF 30 sunscreen and a nighttime cream, which contained combinations of niacinamide, anti-aging peptides, antioxidants and retinyl propionate. The regimen also included daily use of a powered facial cleansing brush in combination with an exfoliating cleanser (Olay Professional Pro-X Advanced Cleansing System). P&G Beauty & Grooming scientists tracked the results of the regimen on each of the twins' facial skin every three months for a total of 10 months.

At the end of the 10-month treatment period, Twin "B" showed nearly the same level of facial hyperpigmentation and essentially the same skin color lightness compared to her sister. These results demonstrate an improvement in facial skin appearance and a noticeable improvement in the visible signs of photoaging when using the Olay Professional Pro-X treatment regimen long term.

'/>"/>

Contact: Megan Lustig mlustig@spectrumscience.com 202-587-2586 Spectrum Source:Eurekalert

0 GOOD

Page: 1 2 3 4
Related biology news :

1. Dont trust liposomes in your beauty products
2. Princess by proxy: When child beauty pageants arent about the kids
3. Can natures beauty lift citizens from poverty?
4. Psychemedics & TruTouch Announce US Sales/Marketing Distribution Agreement For TruTouch Technologies Rapid Optical Alcohol Detection & Biometric Test
5. Government Emerges As the Biggest Spender on Biometrics in the SEA and ANZ Markets, Finds Frost & Sullivan
6. Althea Technologies & Profectus BioSciences Sign Manufacturing Agreement For Plasmid DNA Production
7. FASEB SRC announces conference registration open for: Melatonin Biology: Actions & Therapeutics
8. Synthetic Biologics to Present at the 2013 BIO CEO & Investor Conference
9. FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
10. FASEB SRC announces conference registration open for: NAD Metabolism & Signaling
11. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements